Immunomedics Inc
(IMMU)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2010 | 03-2010 | 12-2009 | 09-2009 | 06-2009 | |
| Cash Flows From Operating Activities | |||||
| Net Income | N/A | 36,252 | 32,782 | 32,012 | N/A |
| Depreciation Amortization | N/A | -44,908 | -41,256 | -37,599 | N/A |
| Other Working Capital | N/A | -464 | -757 | -1,979 | N/A |
| Other Operating Activity | 0 | 1,627 | 905 | 444 | 0 |
| Operating Cash Flow | $N/A | $-7,493 | $-8,326 | $-7,123 | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | -682 | -569 | -259 | N/A |
| Sale Of Investment | N/A | 5,620 | 100 | N/A | N/A |
| Investing Cash Flow | $N/A | $4,938 | $-469 | $-259 | $N/A |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 18 | 15 | 15 | N/A |
| Financing Cash Flow | $N/A | $18 | $15 | $15 | $N/A |
| Beginning Cash Position | N/A | 27,391 | 27,391 | 27,391 | N/A |
| End Cash Position | N/A | 24,854 | 18,611 | 20,023 | N/A |
| Net Cash Flow | $N/A | $-2,537 | $-8,780 | $-7,368 | $N/A |
| Free Cash Flow | |||||
| Operating Cash Flow | N/A | -7,493 | -8,326 | -7,123 | N/A |
| Capital Expenditure | N/A | -682 | -569 | -259 | N/A |
| Free Cash Flow | 0 | -8,175 | -8,894 | -7,383 | 0 |